Barinthus Biotherapeutics Plc (BRNS)
0.7401
-0.02
(-2.49%)
USD |
NASDAQ |
Sep 08, 16:00
0.7628
+0.02
(+3.07%)
After-Hours: 20:00
Barinthus Biotherapeutics Shareholders Equity (Quarterly) : 57.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.07M |
| March 31, 2026 | 66.40M |
| December 31, 2025 | 74.21M |
| September 30, 2025 | 84.46M |
| June 30, 2025 | 102.38M |
| March 31, 2025 | 115.49M |
| December 31, 2024 | 130.03M |
| September 30, 2024 | 159.29M |
| June 30, 2024 | 156.62M |
| March 31, 2024 | 171.83M |
| December 31, 2023 | 186.78M |
| Date | Value |
|---|---|
| September 30, 2023 | 195.40M |
| June 30, 2023 | 217.21M |
| March 31, 2023 | 233.30M |
| December 31, 2022 | 242.90M |
| September 30, 2022 | 243.84M |
| June 30, 2022 | 254.40M |
| March 31, 2022 | 252.74M |
| December 31, 2021 | |
| September 30, 2021 | 241.98M |
| June 30, 2021 | 249.39M |
| March 31, 2021 | 156.13M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.89M |
| Total Liabilities (Quarterly) | 24.76M |
| Debt to Equity Ratio | 0.1804 |
| Current Ratio | 5.539 |
| Net Debt Paydown Yield | 1.20% |